Castleview Partners »

Tenaya Therapeutics shares owned by Castleview Partners

Quarter-by-quarter ownership of Tenaya Therapeutics (TNYA) shares owned by Castleview Partners from 13F filings

Historical chart of Castleview Partners investment in Tenaya Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Tenaya Therapeutics held by Castleview Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Tenaya Therapeutics by Castleview Partners

Quarter filed Position value Share count Share price at filing
2026-03-31 $106k 153k 0.69

More positions owned by Castleview Partners

Valued Advisers Tr Regan Fltg Rate (MBSF)
Advisor Managed Portfolios Regan Fixed Rate (MBSX)
ConocoPhillips (COP)
Apple (AAPL)
Tesla Motors (TSLA)
Managed Portfolio Series Leuthold Select (LST)
Bristol Myers Squibb (BMY)
State Str Spdr S&p 500 Etf T Tr Unit (SPY)
Advisors Inner Circle Fd Ii Pmv Adaptive Rsk (ARP)
Home Depot (HD)
Kkr & Co (KKR)
Vaneck Etf Trust Real Assets Etf (RAAX)
Fidelity Covington Trust High Divid Etf (FDVV)
Amgen (AMGN)
UnitedHealth (UNH)

View all positions for Castleview Partners

Top funds holding Tenaya Therapeutics

Vanguard Group
Vanguard Capital Management
Millennium Management
Citadel Advisors
Empery Asset Management
BlackRock
Kalehua Capital Management
Burkehill Global Management
Renaissance Technologies
Geode Capital Management
ADAR1 Capital Management
Marshall Wace
Two Sigma Investments
Jane Street
GSA Capital Partners

View all funds holding Tenaya Therapeutics